FDA Issues Final Rule Expanding Disqualification of Clinical Investigators for New Animal Drugs

Summary

The US Food and Drug Administration (FDA) has issued a final rule that disqualifies clinical investigators from conducting nonclinical laboratory studies if they are ineligible to receive new animal drugs for investigational use, aiming to protect animal research subjects and ensure data quality.